Philippe Maincent

7.2k total citations
139 papers, 5.8k citations indexed

About

Philippe Maincent is a scholar working on Pharmaceutical Science, Molecular Biology and Biomaterials. According to data from OpenAlex, Philippe Maincent has authored 139 papers receiving a total of 5.8k indexed citations (citations by other indexed papers that have themselves been cited), including 61 papers in Pharmaceutical Science, 25 papers in Molecular Biology and 18 papers in Biomaterials. Recurrent topics in Philippe Maincent's work include Advanced Drug Delivery Systems (48 papers), Drug Solubulity and Delivery Systems (38 papers) and Nanoparticle-Based Drug Delivery (13 papers). Philippe Maincent is often cited by papers focused on Advanced Drug Delivery Systems (48 papers), Drug Solubulity and Delivery Systems (38 papers) and Nanoparticle-Based Drug Delivery (13 papers). Philippe Maincent collaborates with scholars based in France, Germany and China. Philippe Maincent's co-authors include Nathalie Ubrich, Maurice Hoffman, Alf Lamprecht, Christiane Damgé, Rainer Müller, F. Kedzierewicz, A. Sapin, Claus‐Michael Lehr, Roland Bodmeier and Thomas Lecompte and has published in prestigious journals such as Circulation, PLoS ONE and Biomaterials.

In The Last Decade

Philippe Maincent

138 papers receiving 5.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Philippe Maincent France 41 3.0k 1.7k 1.3k 689 542 139 5.8k
Brahmeshwar Mishra India 41 2.7k 0.9× 1.5k 0.9× 978 0.8× 745 1.1× 510 0.9× 190 5.7k
Gilles Ponchel France 46 3.1k 1.0× 1.7k 1.0× 1.3k 1.0× 575 0.8× 463 0.9× 140 5.7k
Vivek Ranjan Sinha India 30 2.8k 0.9× 1.8k 1.0× 935 0.7× 774 1.1× 744 1.4× 98 5.7k
Chong‐Kook Kim South Korea 40 3.0k 1.0× 916 0.5× 1.6k 1.3× 474 0.7× 464 0.9× 175 5.6k
Maurizio Ricci Italy 40 1.8k 0.6× 1.1k 0.6× 1.2k 1.0× 581 0.8× 636 1.2× 179 5.1k
Patrick P. DeLuca United States 42 2.8k 0.9× 1.7k 1.0× 1.6k 1.3× 1.1k 1.6× 445 0.8× 177 5.9k
Carla Caramella Italy 52 3.7k 1.2× 2.1k 1.2× 898 0.7× 782 1.1× 966 1.8× 212 7.4k
Kamla Pathak India 44 3.6k 1.2× 1.0k 0.6× 1.5k 1.2× 423 0.6× 667 1.2× 261 6.8k
Paolo Giunchedi Italy 43 2.7k 0.9× 1.0k 0.6× 1.1k 0.8× 667 1.0× 683 1.3× 152 5.1k
António J. Almeida Portugal 38 2.5k 0.9× 1.2k 0.7× 1.8k 1.4× 911 1.3× 910 1.7× 138 5.9k

Countries citing papers authored by Philippe Maincent

Since Specialization
Citations

This map shows the geographic impact of Philippe Maincent's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Philippe Maincent with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Philippe Maincent more than expected).

Fields of papers citing papers by Philippe Maincent

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Philippe Maincent. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Philippe Maincent. The network helps show where Philippe Maincent may publish in the future.

Co-authorship network of co-authors of Philippe Maincent

This figure shows the co-authorship network connecting the top 25 collaborators of Philippe Maincent. A scholar is included among the top collaborators of Philippe Maincent based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Philippe Maincent. Philippe Maincent is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Benaboura, Ahmed, et al.. (2017). Formulation characterization and in vitro evaluation of acacia gum–calcium alginate beads for oral drug delivery systems. Polymers for Advanced Technologies. 29(2). 884–895. 30 indexed citations
3.
Pape, Elise, Julien Scala‐Bertola, P. Tréchot, et al.. (2015). Trafic de faux médicaments : panorama 2014. Therapies. 70(5). 455–464. 6 indexed citations
4.
Diab, Roudayna, Chiraz Jaafar‐Maalej, Hatem Fessi, & Philippe Maincent. (2012). Engineered Nanoparticulate Drug Delivery Systems: The Next Frontier for Oral Administration?. The AAPS Journal. 14(4). 688–702. 46 indexed citations
5.
Damgé, Christiane, M. Socha, Nathalie Ubrich, & Philippe Maincent. (2009). Poly(ε-caprolactone)/eudragit nanoparticles for oral delivery of aspart-insulin in the treatment of diabetes. Journal of Pharmaceutical Sciences. 99(2). 879–889. 60 indexed citations
6.
Scala‐Bertola, Julien, Jan Gajdziok, Miloslava Rabišková, et al.. (2009). Pellets for oral administration of low-molecular-weight heparin. Drug Development and Industrial Pharmacy. 35(12). 1503–1510. 11 indexed citations
7.
Maincent, Philippe, et al.. (2009). Nanoparticles as Tools for Evaluation of Cellular Redox State. Journal of Biomedical Nanotechnology. 5(6). 641–651. 1 indexed citations
8.
Ubrich, Nathalie, et al.. (2007). Influence of polymers on the bioavailability of microencapsulated celecoxib. Journal of Microencapsulation. 24(7). 621–633. 19 indexed citations
9.
Lamprecht, Alf, Nathalie Ubrich, & Philippe Maincent. (2007). Oral low molecular weight heparin delivery by microparticles from complex coacervation. European Journal of Pharmaceutics and Biopharmaceutics. 67(3). 632–638. 31 indexed citations
10.
Meißner, Yvette, et al.. (2006). Low molecular weight heparin loaded pH-sensitive microparticles. International Journal of Pharmaceutics. 335(1-2). 147–153. 35 indexed citations
11.
Lamprecht, Alf, Nathalie Ubrich, Philippe Maincent, et al.. (2006). Enhanced cellular uptake of a glutathione selective fluorogenic probe encapsulated in nanoparticles. Nanotechnology. 17(10). 2546–2552. 5 indexed citations
12.
Hoffart, Valérie, Nathalie Ubrich, В. Н. Бабак, et al.. (2002). Low Molecular Weight Heparin-Loaded Polymeric Nanoparticles: Formulation, Characterization, and Release Characteristics. Drug Development and Industrial Pharmacy. 28(9). 1091–1099. 71 indexed citations
13.
Gruet, Philippe, Philippe Maincent, Xavier Berthelot, & Vassilios Kaltsatos. (2001). Bovine mastitis and intramammary drug delivery: review and perspectives. Advanced Drug Delivery Reviews. 50(3). 245–259. 213 indexed citations
14.
Ubrich, Nathalie, et al.. (2001). Preparation and In Vitro Evaluation of Heparin-Loaded Polymeric Nanoparticles. Drug Delivery. 8(3). 135–141. 25 indexed citations
15.
Lamprecht, Alf, Nathalie Ubrich, A. Astier, et al.. (2000). The preparation and evaluation of poly(ϵ-caprolactone) microparticles containing both a lipophilic and a hydrophilic drug. Journal of Controlled Release. 65(3). 429–438. 147 indexed citations
16.
Lamprecht, Alf, Nathalie Ubrich, Mary Perez, et al.. (2000). Influences of process parameters on nanoparticle preparation performed by a double emulsion pressure homogenization technique. International Journal of Pharmaceutics. 196(2). 177–182. 147 indexed citations
17.
Ubrich, Nathalie, Jeremiah Ngondi, C. Rivat, et al.. (1997). Selectivein vitro removal of anti-A antibodies by adsorption on encapsulatederythrocyte-ghosts. Journal of Biomedical Materials Research. 37(2). 155–160. 6 indexed citations
18.
Lemoine, Dominique, Camille François, F. Kedzierewicz, et al.. (1996). Stability study of nanoparticles of poly(ɛ-caprolactone), poly(d,l-lactide) and poly(d,l-lactide-co-glycolide). Biomaterials. 17(22). 2191–2197. 182 indexed citations
19.
Maincent, Philippe, Pierre Thouvénot, C Amicabile, et al.. (1992). Lymphatic Targeting of Polymeric Nanoparticles After Intraperitoneal Administration in Rats. Pharmaceutical Research. 9(12). 1534–1539. 59 indexed citations
20.
Anghileri, L.J., Alfredo Córdova, Philippe Maincent, & Jacques Robert. (1991). In vivo behaviour of low molecular weight iron complexes. European Journal of Drug Metabolism and Pharmacokinetics. 16(3). 203–206. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Brahmeshwar Mishra Breakdown of academic impact, for papers by Gilles Ponchel Breakdown of academic impact, for papers by Vivek Ranjan Sinha Breakdown of academic impact, for papers by Chong‐Kook Kim Breakdown of academic impact, for papers by Maurizio Ricci Breakdown of academic impact, for papers by Patrick P. DeLuca Breakdown of academic impact, for papers by Carla Caramella Breakdown of academic impact, for papers by Kamla Pathak Breakdown of academic impact, for papers by Paolo Giunchedi Breakdown of academic impact, for papers by António J. Almeida
Rankless by CCL
2026